When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Catalyst Pharmaceuticals (NASDAQ:CPRX) is scheduled to announce Q4 earnings results on Wednesday, March 16th, after market close. The consensus EPS Estimate is $0.12 (+9.1% Y/Y) and the consensus Revenue Estimate is $38.18M (+23.1% Y/Y). Over the last 1 year, CPRX has beaten EPS estimates 100% of the time and has beaten revenue estimates 50% of the time. Over the last 3 months, EPS estimates have seen 1 upward revision and 0 downward. Revenue estimates have seen 5 upward revisions and 0 downward.